U.S. E-cigarette Regulation Sought By Health Care Stakeholders, Industry
This article was originally published in The Tan Sheet
Executive Summary
The U.K. move to regulate all electronic cigarettes as medical products could help build the case for U.S. regulation by fostering research, experts say. Some e-cigarette firms are anxious for FDA to regulate the products, but also are concerned about the potential impact of CTP oversight.
You may also be interested in...
U.K. Packages All Electronic Cigarettes Under Medical Regulation
The U.K. pharma regulator requires all electronic cigarettes to be licensed as nonprescription medicines beginning in 2016, noting concerns about product quality. Meanwhile, FDA considers allowing e-cigarettes to be marketed as nicotine replacement therapy on a case-by-case basis.
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.